Gene Expression Levels in Predicting Treatment Response in Patients With Stage IV Non-small Cell Lung Cancer

NCT02145078 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Slow accrual.

Conditions

Recurrent Non-small Cell Lung Cancer
Stage IV Non-small Cell Lung Cancer

Interventions

DRUG: docetaxel
DRUG: pemetrexed disodium
DRUG: gemcitabine hydrochloride
OTHER: laboratory biomarker analysis

Sponsor

Barbara Ann Karmanos Cancer Institute

Collaborators

[object Object]